Nitroglycerin

CAS 55-63-0 4 current records 1 historicalSmall Molecule

Who holds supplier records for Nitroglycerin? 4 organisations hold a current record for Nitroglycerin: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (1) and Germany (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nitroglycerin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nitroglycerin

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Nitroglycerin expires 12 Mar 2029. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nitroglycerin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Italy1Germany1Country not recorded for 2
Need Nitroglycerin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Nitroglycerin are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • VICTOR M HERMELIN CO DIV K-V PHARMACAL CO
    Inactive DMF 978 · filed Jul 1966

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (53 listed products contain Nitroglycerin). The latest listed patent expires 12 Mar 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Nitroglycerin is a nitrate vasodilator that dilates blood vessels, improving blood flow and reducing heart workload. It is commonly used for the treatment and prevention of angina pectoris.

Chemical identity

IUPAC name
1,3-dinitrooxypropan-2-yl nitrate
Canonical SMILES
C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
InChIKey
SNIOPGDIGTZGOP-UHFFFAOYSA-N
Synonyms
Nitro-Dur API, c01da02, diluted nitroglycerin, glonoinum, glyceryl trinitrate, glyceryl trinitrate solution, gonitro, imx-150, minitran, nitora, nitro iv, nitro-bid

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Nitrate Vasodilator
Physiologic effect
Vasodilation
Chemical structure
Nitrates

Therapeutic areas

Cardiovascular DiseasesAngina PectorisHeart Failure

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nitroglycerin?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Nitroglycerin: BHARAT PHARMA (A UNIT OF BHARAT EXPLOSIVES LTD), COPPERHEAD INVESTMENTS INC, Dipharma Francis Srl (Italy) and DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK (Germany). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nitroglycerin Drug Master Files are active?

BHARAT PHARMA (A UNIT OF BHARAT EXPLOSIVES LTD) (DMF 27609), COPPERHEAD INVESTMENTS INC (DMF 11595), Dipharma Francis Srl (DMF 24107) and DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIK (DMF 8524). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Nitroglycerin records mean?

1 organisation has only inactive Type II DMFs for Nitroglycerin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Nitroglycerin?

Yes. The latest patent listed for an approved US product containing Nitroglycerin expires 12 Mar 2029, across 53 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Nitroglycerin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nitroglycerin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.